Morgan Stanley sets Novo Nordisk stock at Equalweight
Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...
clinicaltrialsarena2h
OCT West Coast 2025: China surpasses US for annual number of clinical trials
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Daily Express US on MSN2h
Ozempic and Zepbound linked to rare eye conditions that could cause blindness
A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
Novo Nordisk initiated with an Equal Weight at Morgan Stanley
Morgan Stanley initiated coverage of Novo Nordisk (NVO) with an Equal Weight rating and DKK 700 price target The firm says near-term U.S.
Healio27m
Addiction, depression, cognition: How GLP-1s may benefit the brain
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...